alekseykrylov

With a rich background as a Chief Financial Officer (CFO), Aleksey Krylov is a seasoned professional with in-depth expertise in the dynamic arenas of life sciences and medical technology. Aleksey presents a remarkable portfolio of over 70 successful fundraising and M&A transactions, showcasing his adeptness in steering companies through diverse strategic opportunities.

Holding an MBA from Columbia Business School and a Bachelor of Science in Business Administration from Babson College, Aleksey's financial acumen is further illuminated in his transformative role as the CFO of CytoImmune Therapeutics where he secured over $100 million in funding.